These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11925318)

  • 1. Topiramate for refractory schizophrenia.
    Millson RC; Owen JA; Lorberg GW; Tackaberry L
    Am J Psychiatry; 2002 Apr; 159(4):675. PubMed ID: 11925318
    [No Abstract]   [Full Text] [Related]  

  • 2. Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia.
    Levy E; Margolese HC; Chouinard G
    J Clin Psychiatry; 2002 Nov; 63(11):1045. PubMed ID: 12469686
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychotic symptoms associated with topiramate: cognitive side effects or worsening of psychosis?
    Duggal HS
    J Clin Psychiatry; 2004 Aug; 65(8):1145; author reply 1145--6. PubMed ID: 15323603
    [No Abstract]   [Full Text] [Related]  

  • 4. Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study.
    Muscatello MR; Bruno A; Pandolfo G; Micò U; Bellinghieri PM; Scimeca G; Cacciola M; Campolo D; Settineri S; Zoccali R
    J Psychopharmacol; 2011 May; 25(5):667-74. PubMed ID: 20615930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial.
    Afshar H; Roohafza H; Mousavi G; Golchin S; Toghianifar N; Sadeghi M; Talaei M
    J Psychopharmacol; 2009 Mar; 23(2):157-62. PubMed ID: 18515465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate add-on in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
    Tiihonen J; Halonen P; Wahlbeck K; Repo-Tiihonen E; Hyvärinen S; Eronen M; Putkonen H; Takala P; Mehtonen OP; Puck M; Oksanen J; Koskelainen P; Joffe G; Aer J; Hallikainen T; Ryynänen OP; Tupala E
    J Clin Psychiatry; 2005 Aug; 66(8):1012-5. PubMed ID: 16086616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
    McElroy SL; Frye MA; Altshuler LL; Suppes T; Hellemann G; Black D; Mintz J; Kupka R; Nolen W; Leverich GS; Denicoff KD; Post RM; Keck PE
    Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worsening of psychosis or topiramate-induced adverse event?
    Duggal HS; Singh I
    Gen Hosp Psychiatry; 2004; 26(3):245-7. PubMed ID: 15121357
    [No Abstract]   [Full Text] [Related]  

  • 9. Topiramate augmentation in clozapine-treated patients with schizophrenia: clinical and metabolic effects.
    Hahn MK; Remington G; Bois D; Cohn T
    J Clin Psychopharmacol; 2010 Dec; 30(6):706-10. PubMed ID: 21105286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do anticonvulsants hinder clozapine treatment?
    Wilson WH
    Biol Psychiatry; 1995 Jan; 37(2):132-3. PubMed ID: 7718678
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperthermia and rhabdomyolysis in an adolescent treated with topiramate and olanzapine.
    Strawn JR; Adler CM; Strakowski SM; DelBello MP
    J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):116-8. PubMed ID: 18294095
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictors of clinical worsening after a switch to aripiprazole in patients with schizophrenia: a 1-year naturalistic follow-up study.
    Takeuchi H; Uchida H; Suzuki T; Watanabe K; Kashima H
    J Clin Psychopharmacol; 2009 Aug; 29(4):394-5. PubMed ID: 19593185
    [No Abstract]   [Full Text] [Related]  

  • 13. Worsening of psychosis after replacement of adjunctive valproate with topiramate in a schizophrenia patient.
    Hofer A; Fleischhacker WW; Hummer M
    J Clin Psychiatry; 2003 Oct; 64(10):1267-8. PubMed ID: 14658980
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of topiramate augmentation in chronic schizophrenia: a placebo-controlled trial.
    Behdani F; Hebrani P; Rezaei Ardani A; Rafee E
    Arch Iran Med; 2011 Jul; 14(4):270-5. PubMed ID: 21726104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: a double-blind, placebo-controlled study.
    Zoccali R; Muscatello MR; Bruno A; Cambria R; Micò U; Spina E; Meduri M
    Schizophr Res; 2007 Jul; 93(1-3):109-16. PubMed ID: 17383857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitigating cognitive side effects associated with topiramate.
    Antai-Otong D
    Perspect Psychiatr Care; 2005; 41(2):92-3. PubMed ID: 15924583
    [No Abstract]   [Full Text] [Related]  

  • 17. Topiramate and fulminant liver failure.
    Bjøro K; Gjerstad L; Bentdal O; Osnes S; Schrumpf E
    Lancet; 1998 Oct; 352(9134):1119. PubMed ID: 9798593
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term treatment retention with topiramate.
    Deckers CL; Renier WO
    Epilepsia; 2001 Feb; 42(2):290-1. PubMed ID: 11240609
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of buspirone in seven schizophrenic subjects.
    Brody D; Adler LA; Kim T; Angrist B; Rotrosen J
    J Clin Psychopharmacol; 1990 Feb; 10(1):68-9. PubMed ID: 1968473
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis.
    Gobbi G; Gaudreau PO; Leblanc N
    J Clin Psychopharmacol; 2006 Oct; 26(5):467-73. PubMed ID: 16974186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.